Heat Biologics to Present at LHA Life Sciences & Medical Technologies Virtual Conference
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Heat Biologics, Inc. (the “Company” or “Heat”), a clinical-stage immunotherapy company, today announced that Jeffrey Wolf, Chief Executive Officer of Heat Biologics, will present to investors as part of the LHA Life Sciences & Medical Technologies Virtual Conference on Thursday, February 16, 2012, at 10:00 a.m. Eastern time.